載入...
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
The first approved Janus kinase (JAK) inhibitors for treatment of RA targeted more than one JAK molecule. Although this brings an advantage of simultaneous blocking of more cytokines involved in RA, it may also carry an increased risk of toxicity. Subsequently, more selective JAK inhibitors were dev...
Na minha lista:
| 發表在: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098113/ https://ncbi.nlm.nih.gov/pubmed/33950228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa893 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|